Blood test may replace scopes for IBD diagnosis
NCT ID NCT07400211
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study explores whether measuring two specific genes (NEAT1 and ANRIL) in blood samples can help diagnose inflammatory bowel disease (IBD) without needing a colonoscopy. Researchers will test blood from 62 newly diagnosed IBD patients and look for links between these genes and inflammation markers. If the approach works, it could lead to a simple, non-invasive diagnostic tool.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test to help diagnose inflammatory bowel disease without invasive procedures.
- What could go wrong
- This is a small, early-stage study with only 62 participants. The biomarkers may not prove accurate enough for clinical use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE (IBD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill tame inflammatory bowel disease? early safety trial begins
- Can a mediterranean diet and Time-Restricted eating tame gut inflammation?
- Could early lipid screening in High-Risk kids prevent future heart attacks?
- Two-Drug cocktail aims to tame stubborn Crohn's disease
- Dutch hospital data reveals hidden patterns in IBD treatment
- Acupuncture points may signal hidden disease activity